Adenine, thymine and cytosine PNA monomers have been prepared using 3-amino-1,2-propanediol as a starting material. The benzoyl group was used to protect the exocyclic amines of the heterocyclic bases of A and C PNA monomers and the backbone primary amine was protected with the monomethoxytrityl group. The thymine and cytosine PNA monomers were used in conjunction with standard DNA synthesis monomers to produce chimeric PNA DNA (PDC) oligomers. Ultraviolet melting studies confirmed that these oligomers form stable hybrids with complementary DNA strands and that mismatches in the DNA but more so in the PNA sections lead to duplex destabilisation.
INTRODUCTION
Since the first report of the synthesis of peptide nucleic acids (PNAs) (1) there have been many reports describing the binding of PNA to DNA and to RNA (2) , the biological applications of PNA (3) (4) (5) (6) and structural variations of the basic PNA structure ( Fig. 1 ) including the use of elongated (7, 8) and chirally modified backbones (9, 10) . Here we describe the synthesis of PNA monomers which are compatible with solid-phase DNA synthesis and the assembly on solid-phase of DNA-PNA chimeras (Fig. 2 ) which have potential applications in biology.
PNAs are uncharged at physiological pH and one of the major drawbacks to their use is their poor water solubility. However the lack of backbone charge also gives rise to unusual hybridisation behaviour which is potentially of great value in molecular biology. There are no electrostatic interstrand repulsions when PNAs hybridise with nucleic acids and this leads to higher thermodynamic stability than structurally analogous DNA-DNA or RNA-DNA hybrids (11) . In addition, in contrast to DNA-DNA hybrids, PNA-DNA hybrids are stable under low salt conditions and it has been shown that PNA and DNA strands have a faster rate of binding relative to DNA-DNA strands (12) .
It is possible that PNA-DNA chimeric oligomers in which both types of monomeric unit are present in a single chain might combine the favourable hybridisation characteristics of PNA with the high water solubility of DNA. Moreover, the structure of such molecules, if it bears a resemblance to DNA, might be compatible with some enzyme catalysed reactions. Such compounds could therefore be of use in PCR, DNA sequencing, antisense inhibition studies and other technologies.
RESULTS AND DISCUSSION

Synthesis of PNA monomers
Our strategy to produce such molecules was to assemble a DNA chain on a solid support using standard phosphoramidite coupling chemistry and then to couple the PNA monomers in a stepwise manner to produce a chimeric molecule with a 5′ PNA segment and a 3′ DNA segment (Fig. 2) . In order to achieve this objective we prepared PNA monomers with the same protection chemistry as conventional DNA phosphoramidites. From the outset it was clear that t-butyloxycarbonyl (boc) protection of the PNA N-terminus was not desirable since the TFA used in bocdeprotection is not compatible with oligodeoxynucleotides which depurinate rapidly in acidic media. 9-Fluorenylmethoxycarbonyl (Fmoc) protection was equally unsuitable because its removal with base would lead to cleavage of the oligonucleotide from the solid support. Bergmann et al. have shown that these problems can be overcome (13) but in the interests of simplicity and convenience we opted to use the monomethoxytrityl group for N-terminus protection. We adopted a similar approach to that used by Will et al. in PNA synthesis (14) and by van der Laan et al. (15) and Stetsenko et al. (16) in the synthesis of oligo dT and U/dT PNA-DNA hybrids. Benzyloxycarbonyl protection of the exocyclic amino groups of the A and C monomers has been used extensively in PNA synthesis but is not suitable for PNA-DNA chimeras since the hydrogenolysis or acidolysis required to remove this group would add a further deprotection step which could damage the DNA portion of the chimera. Therefore the PNA bases were protected with the benzoyl group, the same as the bases of the corresponding DNA phosphoramidites.
The N(2-aminoethyl)glycine backbone of PNA was prepared originally by alkylation of ethylene diamine with chloroacetic acid (17) . Related monomers have been made by utilising the Michael addition of mono-boc ethylenediamine to ethyl acrylate (18) . We found the most reliable method to be that shown in Scheme 1. Boc protection of 3-aminopropane-1,2-diol was preferred to monomethoxytrityl protection at this early stage due to the higher stability of this group in subsequent reaction steps. 3-Amino-1,2-propanediol 1 was treated with boc anhydride to produce 3-t-butoxycarbonylamino-1,2-propanediol 2 in quantitative yield. Periodiate cleavage of the vicinal diol 2 afforded the protected amino aldehyde 3 in high yield, reductive amination of which with sodium cyanoborohydride and ethyl glycinate gave ethyl N(2-bocaminoethyl)glycinate 4 in 43% yield. The use of sodium borohydride during the reductive amination was not successful as it resulted in only 24% conversion of 3 to 4 and also led to the formation of several impurities including t-butyloxycarbonyl aminoethanol from the reduction of aldehyde 3.
The heterocyclic bases were coupled to an acetic acid moiety for subsequent formation of the PNA monomers as follows: thymine N(1)-acetic acid 5 was prepared (Scheme 2) by treating thymine with aqueous bromoacetic acid and sodium hydroxide (6) . The 4-amino group of cytosine (Scheme 3) was protected by reaction with benzoyl chloride to give N(4)-benzoylcytosine 6 which was alkylated at N(1) with methyl bromoacetate in DMF (6) to give N(4)-benzoylcytosine N(1)-acetic acid methyl ester 7. Selective hydrolysis of 7 with aqueous NaOH at room temperature gave N(4)-benzoylcytosine N(1)-acetic acid 8. Adenine was alkylated at N(9) by treatment with sodium hydride in DMF followed by addition of methyl bromoacetate to give N(9)-adenine acetic acid methyl ester 9 (Scheme 4) according to established procedures (19) . There was no evidence of alkylation at adenine N(7) either by t.l.c. or 1 H NMR analysis. After recrystallisation of ester 9 from H 2 O/EtOH, the 6-amino group was protected by treatment with a slight excess of benzoyl chloride in pyridine to afford the mono-benzoylated amine 10 which was hydrolysed with aqueous sodium hydroxide at room temperature to afford the acid 11.
The methodology for adding the heterocyclic bases to the PNA monomeric backbone is shown in Scheme 5. The amine 4 was condensed with acids 5, 8 and 11 respectively to give the boc protected PNA monomer esters 12-14. The coupling yields were in the range 30-40% when DCC/HOBT were used to activate the acids. The low yield may be a consequence of the insolubility of the acids in DMF and steric hindrance inhibiting the formation of a tertiary amide. The use of PyBroP (20) to activate the acids resulted in ∼60% yields of 12-14 while optimum yields of 70-80% were achieved by the use of TopPipU, a recently introduced reagent for the preparation of sterically hindered amides (21) .
Intermediates 12-14 were deprotected with TFA to give the free amines which were alkylated with monomethoxytrityl chloride to give the MMTr protected amines 15-17. These were then treated with cold aqueous sodium hydroxide and the acids 18-20 were isolated following neutralisation with pyridinium DOWEX.
Synthesis of PNA-DNA chimeric oligomers (PDC oligomers)
The PDC oligomers were assembled with the DNA section at the 3′-end and the PNA section at the 5′-end (N-terminus, Fig. 2 ). In principle this would allow for template directed extension of the DNA chain in subsequent enzymic reactions. Previously a modified PNA thymine monomer bearing a dimethoxytrityloxyethyl group has been used to couple PNA thymine units to the '3′-end' of DNA (22) (the opposite orientation). In our work DNA sections were synthesised using standard phosphoramidite chemistry and the modified nucleoside 5′-(4-methoxytrityl)amino-5′-deoxy-thymidine phosphoramidite (23) was added as a linker between PNA and the 5′-end of the DNA chain. The PNA monomers were added using TopPipU as activating agent and deprotection of the monomethoxytrityl terminal amino functions prior to each PNA coupling step was carried out using TCA (3% w/v in dichloromethane). Capping of unreacted amino groups was achieved using acetic anhydride in pyridine. Solution and solid-phase reactions showed that the adenine PNA monomer failed to couple efficiently under these conditions and this is the subject of continuing work. In the present study only cytosine and thymine PNA monomers were used for oligomer synthesis. The chimeric oligomers were cleaved from the solid support and the exocyclic amino protecting groups were removed by heating the resin in concentrated aqueous ammonia at 55_C for 6 h. The crude products were purified by reversed-phase HPLC, desalted by Sephadex gel filtration and analysed by capillary electrophoresis (Figs 3 and 4) . This single purification protocol gave oligomers with only minor levels of impurities.
Ultraviolet melting studies
Ultraviolet melting studies ( Table 1 ; 24) of the PDC sequences Ac-tttcttTGCCAT-3′ and Ac-ttttttTGCCAT-3′ (PDC = PNA-DNA chimera, Ac = acetyl on the amino group of the terminal PNA residue, DNA residues in upper case, PNA residues in lower case) with their DNA complements indicate increased stability of the PDC-DNA duplex with respect to the native DNA duplexes (an increase in T m of 10.2_C in the former and 7.7_C in the latter case). The inter-strand interaction between the chimera and the complementary DNA strand was shown to occur in a sequence specific manner. In the case of Ac-ttttttTGCCAT-3′ a G·t mismatch in the centre of the PNA part of the chimeric strand opposite the DNA strand gave a drop in T m of 16.2_C whereas a C·C mismatch in the DNA part of the chimera gave a drop in T m of only 2.8_C. This suggests that the duplex is stabilised much more by PNA-DNA interactions than DNA-DNA interactions and that mismatches in the PNA section are very destabilising. This was confirmed with the sequence Ac-tttcttTGCCAT-3′ in which a PNA-DNA A.c mismatch caused a massive drop in T m of 37.3_C whereas a C·C mismatch involving the DNA portion of the chimera caused a drop in T m of only 1.9_C.
CONCLUSION
We have demonstrated that PNA-DNA chimeric oligomers can be synthesised in a stepwise fashion using PNA monomers which are compatible with DNA synthesis and we have confirmed that the chimeras hybridise specifically to complementary DNA. The PDC oligomers form more stable complexes with complementary DNA than do the equivalent DNA sequences. 
EXPERIMENTAL
All solvents were of analytical grade; dichloromethane (DCM), diethylcyclohexylamine (DECHA) and pyridine were distilled over CaH 2 ; methanol (MeOH) was distilled over Mg and I 2 ; tetrahydrofuran (THF) was distilled over sodium and benzophenone, N,N-dimethylformamide (DMF) was of peptide synthesis grade and DNA synthesis grade acetonitrile was purchased from Perkin-Elmer Ltd. TopPipU was obtained from Novabiochem. All other chemicals were supplied by Aldrich, Sigma or Fluka. 1 H and 13 C NMR were recorded on Brucker 250AC and Brucker 200WP spectrometers. Positive ion Fast Atom Bombardment (FAB) mass spectra were recorded on a Kratos MS50TC spectrometer using a thioglycerol matrix, chemical ionisation (C.I.) mass spectra were recorded on a VG analytical 70-250 SE Normal Geometry Double Focus Mass Spectrometer and electrospray mass spectra were recorded on a VG Biotech Platform.
Flash chromatography was carried out using silica gel 60 (Fluka). Thin layer chromatography (TLC) was carried out on aluminium sheets, silica 60 F 254 , 0.2 mm layer (Merck) using the following solvent systems; A = n-butyl alcohol/acetic acid/H 2 O (3:1:1 v:v), Table 1 . Ultraviolet melting temperatures of PDC-DNA and DNA-DNA duplexes DNA units in upper case, PNA units in lower case. Ultraviolet melting temperatures (T m ) were determined at 260 nm with a heating rate of 0.5 K/min. Oligonucleotides were dissolved in a buffer consisting of 0.14 M NaCl and 10 mM HEPES adjusted to pH 7.0. B = DCM/ethyl acetate (1:1 v/v), C = DCM/MeOH (9/1 v/v). Products were visualised using ninhydrin (1% w/v in EtOH) with heating for 5 min, UV irradiation at 254 nm, iodine oxidation or phosphomolybdic acid (10% w/v in water) with heating.
3-t-Butoxycarbonylamino-1,2-propanediol 2
To an ice-cooled solution of racemic 3-amino-1,2-propanediol (10 g, 0.11 mol) in water (250 ml) was added boc anhydride (25 g, 0.12 mol). The mixture was allowed to warm to room temperature and the pH was maintained at 10.5 by the addition of aqueous NaOH (2N). The solution was concentrated to a paste which was triturated with DCM (500 ml). The suspension was filtered and the organic phase was dried (MgSO 4 
t-Butoxycarbonylaminoacetaldehyde 3
To diol 2 (5 g, 26.1 mmol) in water (50 ml) was added NaIO 4 (6.8 g, 1.2 eq.) at room temperature with stirring. After 3 h the mixture was filtered, extracted with DCM (5 × 100 ml) and the combined organic phases were dried (MgSO 4 ) and concentrated to yield the aldehyde 3 (3.9 g, 94%) as an oil. 
Ethyl-N-[2-(t-butoxycarbonylamino)ethyl] glycinate 4
To t-butoxycarbonylaminoacetaldehyde 3 (5.13 g, 32.2 mmol) in MeOH (100 ml) was added ethyl glycinate hydrochloride (11.2 g, 2.5 eq.) and NaBH 3 CN (2.02 g, 1 eq.) with stirring at room temperature. After 16 h the mixture was evaporated, the residue dissolved in water (100 ml) and the pH adjusted to 8.0 by the addition of aqueous NaOH (2 M). The solution was extracted with DCM (5 × 150 ml) and the combined organic fractions were dried (MgSO 4 ) and evaporated to give 4 as a colourless oil (3.42 g, 43%) Nucleic Acids Research, 1996, Vol. 24 
Thymine-1-acetic acid 5
To a solution of thymine (10.0 g, 79.3 mmol) and KOH (17.1 g, 3.8 eq.) in water (50 ml) was added dropwise, with stirring, bromoacetic acid (16.5 g, 1.5 eq.) in water (25 ml) at 40_C over 30 min. After 2 h the solution was cooled to room temperature and the pH was adjusted to 5.5 by the addition of conc. HCl. A precipitate was removed after 2 h at -4_C and the pH of the filtrate was adjusted to 2.0 (conc. HCl). The acid 5 (12.5 g, 86%) was collected and dried over P 2 
N(4)-benzoylcytosine 6
Cytosine (10.0 g, 0.09 mol) was suspended in pyridine (750 ml) and benzoyl chloride (21.0 ml, 2 eq.) added dropwise with stirring over 3 h. The reaction mixture was stirred at room temperature for a further 1 h after which the pH was adjusted to 5.0 by the addition of 4 N HCl. The resulting suspension was stirred at room temperature for a further 2 h and the precipitate collected, washed with EtOH (3 × 100 ml) and dried in vacuo over P 2 O 5 
N(4)-Benzoyl cytosine-N(1)-acetic acid 8
N(4)-benzoylcytosine 6 (5.00 g, 23 mmol) and potassium carbonate (3.20 g, 1 eq.) were suspended in DMF (100 ml) and methyl bromoacetate (2.24 ml, 1 eq.) was added dropwise with stirring over 3 h. Stirring was continued at room temperature for 16 h then the suspension filtered. The filtrate was evaporated to dryness, water (75 ml) and HCl (4N, 2.5 ml) added and the precipitate collected and suspended in water (40 ml). NaOH (2 N, 30 ml) was added and the solution was stirred at room temperature for 30 min then filtered. To the filtrate was added conc. HCl (5 ml), and the precipitate was collected and dried in-vacuo to afford the title acid (2.80 g, 45%). R f 0. 
Adenine-N(9)-acetic acid methyl ester 9
A 60% dispersion of sodium hydride in paraffin, (3.26 g, 0.82 mol) was washed with hexane (3 × 100 ml) then suspended in DMF (250 ml) at 0_C. To this was added adenine (10.0 g, 0.74 mol) slowly with stirring. On completion of addition the reaction mixture was warmed to room temperature and stirred for 2 h before methyl bromoacetate (12.9 ml, 1.8 eq.) was added over 3 h with continual stirring. The reaction mixture was stirred at room temperature for a further 16 h then the solution was concentrated to a paste. Water (100 ml) was added and the precipitate collected and recrystallised from EtOH/water (3:2 v/v, 120 ml), to give the title ester (11.4 g, 75%) . R f 0.55 (A), 0.12 (C). Benzoyladenine-N(9)-acetic acid methyl ester 10 Compound 9 (5.00 g, 0.024 mol) was coevaporated with pyridine (3 × 10 ml) then redissolved in pyridine (50 ml). Benzoyl chloride (3.1 ml, 1.1 eq.) in pyridine (50 ml) was added dropwise over 3 h at room temperature and stirring was continued for 16 h. Water (100 ml) was added then the reaction mixture was extracted with DCM (3 × 100 ml). The combined extracts were washed with NaHCO 3 (0.5N, 3 × 100 ml), NaCl (sat., 100 ml), dried (Na 2 SO 4 
N(6)-
N(6)-Benzoyladenine-N(9)-acetic acid 11
Compound 10 (4.41 g, 0.14 mol) was suspended in MeOH (80 ml) at 0_C. NaOH (2N, 80 ml) was added and the reaction mixture stirred at 0_C for 30 min. The solution was washed with DCM (2 × 80 ml) then the pH adjusted to 1 by the addition of conc. HCl (5 ml). The title acid (3.43 g, 72%) was collected and dried over P 2 
N-(t-Butoxycarbonylaminoethyl)-N-(thyminyl-N(1)-acetyl)-glycine ethyl ester 12
Ethyl-N-[2-(t-butoxycarbonylamino)ethyl] glycinate 4 (2.75 g, 11 mmol) and thymine-N(1)-acetic acid 5 (2.05 g, 1 eq.) were dissolved in DMF (25 ml) and triethylamine (4.42 ml, 3 eq.) was added. TopPipU (4.2 g, 1.0 eq.) was added and the reaction mixture was stirred at ambient temperature for 16 h. The solvent was removed by evaporation and DCM (250 ml) was added to the residue. The resultant solution was washed with NaHCO 3 (0.5 N, 3 × 100 ml), citric acid (10% w/v, 2 × 100 ml), and saturated NaCl (100 ml), dried (MgSO 4 ) then concentrated to an oil which was subjected to flash column chromatography [DCM/MeOH (0-3%)]. The ester 12 (3.2 g, 71%) was isolated as a foam. R f 0.75 (A), 0.15 (B), 0.33 (C); δ H (CDCl 3 ); (two rotational isomers in the ratio 2:1 were detected due to restricted rotation about the tertiary amide bond) 1 
